Beste apotheek van Nederland

Pohanka M, Kanovsky P, Bares M et al. The long-lasting
improvement of sexual dysfunction in patients with advanced,
fluctuating Parkinson's disease induced by pergolide: evidence
from the results of an open, prospective, one-year trial.
Parkinsonism Relat Disord 2005;11(8):509-512.
Pohanka M, Kanovsky P, Bares M et al. Pergolide mesylate can
improve sexual dysfunction in patients with Parkinson's disease:
the results of an open, prospective, 6-month follow-up. Eur J
Neurol 2004;11(7):483-488.
Polak K, Wimpissinger B, Berisha F et al. Effects of sildenafil
on retinal blood flow and flicker-induced retinal vasodilatation
in healthy subjects. Invest Ophthalmol Vis Sci
2003;44(11):4872-4876.
Pomara G, Morelli G, Montorsi F et al. Re: Montorsi F, Salonia
A, Briganti A, Barbieri L, Zanni G, Surdi N, Cestari A,
Montorsi P, Rigatti P. Vardenafil for the treatment of erectile
dysfunction: A critical review of the literature based on personal
clinical experience. Eur Urol 2005;47:612-21 (multiple letters).
Eur Urol 2005;48(2):345-346.
Pomara G, Morelli G, Pomara S et al. Cardiovascular parameter
changes in patients with erectile dysfunction using pde-5
inhibitors: a study with sildenafil and vardenafil. J Androl
2004;25(4):625-629.
Pommerville P. Drug treatments for erectile dysfunction: An
update. Geriatrics and Aging 2004;7(6):10-16.
Porst H. IC351 (tadalafil, Cialis): update on clinical experience.
[Review] [12 refs]. Int J Impot Res 2002;14Suppl-64.
Porst H. Transurethral alprostadil with MUSE (medicated
urethral system for erection) vs intracavernous alprostadil--a
comparative study in 103 patients with erectile dysfunction.. Int
J Impot Res 1997;9(4):187-192.
Porst H. Phosphodiesterase type-5 inhibitors: A critical
comparative analysis. Eau Update Series 2004;2(2):56-63.
Porst H, Lungimayr G, utsch-osterreichische S T E A. [Efficacy
and tolerability of vardenafil within the time window of 6 hours
after administration and beyond. Results of a clinical study
carried out in 233 urological offices]. MMW Fortschr Med
2005;147(Suppl 1):27-32.
Potempa A J, Ulbrich E, Bernard I et al. Efficacy of vardenafil
in men with erectile dysfunction: a flexible-dose community
practice study. Eur Urol 2004;46(1):73-79.
Pradeep C, Car N, Metelko Z. Impotence in diabetic men.
Diabetol Croat 1996;25(2):61-68.
Price D. Sildenafil citrate (Viagra) efficacy in the treatment of
erectile dysfunction in patients with common concomitant
conditions. Sildenafil Study Group. Int J Clin Pract
1999;Supplement.102-103.
Price D E, Cooksey G, Jehu D et al. The management
of impotence in diabetic men by vacuum tumescence
therapy. Diabet Med 1991;8(10):964-967.
Prieto Castro R M, nglada Curado F J, Regueiro
Lopez J C et al. Treatment with sildenafil citrate in
renal transplant patients with erectile dysfunction.
BJU Int 2001;88(3):241-243.
Priyadarshi S. Oral terbutaline in the management of
pharmacologically induced prolonged erection. Int J
Impot Res 2004;16(5):424-426.
Pryor J. Vardenafil: update on clinical experience.
[Review] [10 refs]. Int J Impot Res 2002;14Suppl-9.
Purvis K, Brekke I, Christiansen E. Determinants of
satisfactory rigidity after intracavernosal injection
with prostaglandin E1 in men with erectile failure. Int
J Impot Res 1996;8(1):9-16.
Radomski S B, Herschorn S, Rangaswamy S. Topical
minoxidil in the treatment of male erectile
dysfunction. Br J Urol 1994;151(5):1225-1226.
Raffaele R, Vecchio I, Giammusso B et al. Efficacy
and safety of fixed-dose oral sildenafil in the treatment
of sexual dysfunction in depressed patients with
idiopathic Parkinson's disease. Eur Urol
2002;41(4):382-386.
Raina R, Agarwal A, Allamaneni S S et al. Sildenafil
citrate and vacuum constriction device combination
enhances sexual satisfaction in erectile dysfunction
after radical prostatectomy. Urology 2005;65(2):360­
364.
Raina R, Agarwal A, Goyal K K et al. Long-term
potency after iodine-125 radiotherapy for prostate
cancer and role of sildenafil citrate. Urology
2003;62(6):1103-1108.
Raina R, Lakin M M, Agarwal A et al. Long-term
intracavernous therapy responders can potentially
switch to sildenafil citrate after radical prostatectomy.
Urology 2004;63(3):532-537.
Raina R, Lakin M M, Agarwal A et al. Efficacy and
factors associated with successful outcome of
sildenafil citrate use for erectile dysfunction after
radical prostatectomy. Urology 2004;63(5):960-966.
Raina R, Lakin M M, Agarwal A et al. Long-term
effect of sildenafil citrate on erectile dysfunction after
radical prostatectomy: 3-year follow-up. Urology
2003;62(1):110-115.
Raina R, Lakin M M, Thukral M et al. Long-term
efficacy and compliance of intracorporeal (IC)
injection for erectile dysfunction following radical
prostatectomy: SHIM (IIEF-5) analysis. Int J Impot
Res 2003;15(5):318-322.
D-117